Eugene Timothy Sullivan

Affiliations

  • Chief Financial Officer at Apellis Pharmaceuticals Inc. (APLS), 2025-06-11
  • Director at G1 Therapeutics Inc. (GTHX), 2017-05-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
APLS $29.71 11,699 $347,629.94 11,699 2019-08-29 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
APLS $29.52 546 $16,119.89 128,665 2025-01-29 Filing
APLS $30.43 3,088 $93,953.94 129,211 2025-01-22 Filing
APLS $29.96 1,730 $51,827.69 86,370 2025-01-17 Filing
APLS $28.70 2,170 $62,283.56 88,100 2025-01-13 Filing
APLS $58.66 4,000 $234,640.00 93,338 2024-04-01 Filing